Mutations in islet proteins themselves, by changing the affinity of peptide(s) containing them for either MHC class I or MHC class II, may enhance or diminish MHC presentation of these autoantigens to affect T1D susceptibility. This evidence concerns the gene HLA-C and type 1 diabetes mellitus.